The Enterprise Value as of November 2024 (TTM) for Lyra Therapeutics, Inc. (LYRA) is 23.90M

According to Lyra Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 23.90M. This represents a change of -87.73% compared to the average of 194.77M of the last 4 quarters.

Lyra Therapeutics, Inc. (LYRA) Historical Enterprise Value (quarterly & annually)

How has LYRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Lyra Therapeutics, Inc. over the last ten years is 115.67M. The current 23.90M Enterprise Value has changed 1.97% with respect to the historical average. Over the past ten years (40 quarters), LYRA's Enterprise Value was at its highest in in the March 2024 quarter at 422.13M. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Lyra Therapeutics, Inc. (LYRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lyra Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lyra Therapeutics, Inc. (LYRA) Average Enterprise Value

How has LYRA Enterprise Value performed in the past?

The current Enterprise Value of Lyra Therapeutics, Inc. (LYRA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Lyra Therapeutics, Inc. (LYRA) Enterprise Value vs. Peers

How is LYRA’s Enterprise Value compared to its peers?

Lyra Therapeutics, Inc.’s Enterprise Value is less than CytomX Therapeutics, Inc. (39.67M), less than Assembly Biosciences, Inc. (68.59M), greater than Achilles Therapeutics plc (-38865958.00), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Instil Bio, Inc. (165.40M), greater than NextCure, Inc. (11.01M), greater than Spero Therapeutics, Inc. (-8426888.00), less than Nuvation Bio Inc. (923.54M), less than Cullinan Oncology, Inc. (630.54M), less than Bolt Biotherapeutics, Inc. (30.96M), less than Day One Biopharmaceuticals, Inc. (963.46M), less than Autolus Therapeutics plc (177.55M),

Build a custom stock screener for Lyra Therapeutics, Inc. (LYRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lyra Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lyra Therapeutics, Inc. (LYRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lyra Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.